As of 2025-06-20, the Fair Value of Voyager Therapeutics Inc (VYGR) is -38.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.04 USD, the upside of Voyager Therapeutics Inc is -1,358.56%.
With the market price of 3.04 USD and our fair value calculation, Voyager Therapeutics Inc (VYGR) is not a good investment. Investing in VYGR stocks now will result in a potential loss of 1,358.56%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 36.70 | -71.20 | -46.40 | 132.33 | -65.00 | -2.71 |
| YoY growth | 184.17% | -294.01% | 34.83% | 385.19% | -149.12% | 32.21% |
| Market Cap (mil) | 168.23 |
| P/E | |
| Forward P/E |
| EPS | -1.53 |
| Avg earnings growth rate | 32.21% |
| TTM earnings | -84.69 |